Full name
MEMOPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
47.91.Z - Retail sale via mail order houses or via Internet
63.11.Z - Data processing, hosting and related activities
70.22.Z - Business and other management consultancy activities
73.1 - Advertising
82.92.Z - Packaging activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,1 | 1,4 | 1 | -29,3 |
EBITDA | 1,1 | 1,4 | 1 | -28,9 |
Short time liabilities | 1,6 | 1,3 | 1,2 | -7,8 |
Equity capital | 3 | 4,2 | 4,9 | 18,6 |
Operating profit (EBIT) | 1,1 | 1,4 | 1 | -28,9 |
Assets | 4,7 | 5,5 | 6,1 | 12,2 |
Net profit (loss) | 1 | 1,1 | 0,8 | -30,3 |
Cash | 1,4 | 1,7 | 2,4 | 46,2 |
Net income from sale | 17,5 | 18,9 | 18,8 | -0,3 |
Liabilities and provisions for liabilities | 1,6 | 1,3 | 1,2 | -7,8 |
Working assets | 4,7 | 5,5 | 6,1 | 12,3 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 31,8 | 26,7 | 15,7 | -11 |
Equity capital to total assets | 65,2 | 76 | 80,3 | 4,3 |
Gross profit margin | 6,4 | 7,2 | 5,1 | -2,1 |
EBITDA Margin | 6,4 | 7,2 | 5,2 | -2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 34 | 25 | 24 | -1 |
Current financial liquidity indicator | 2.868189811706543 | 4.153700351715088 | 5.059535026550293 | 0,9 |
Net dept to EBITDA | -1.0107418298721313 | -1.1367855072021484 | -2.500659227371216 | -1,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane